With nearly 100 years of history, the Fleury Group is one of the most respected brands in Brazil, recognized for its excellence in diagnostic medicine, innovation, and contribution to the population’s health. In a fast-changing industry, the company has outlined an ambitious strategy: to establish itself as a healthcare giant in Brazil by offering increasingly comprehensive, integrated, and sustainable solutions and experiences in people’s health and well-being journeys.
In 2021, Jeane Tsutsui took over as CEO after more than two decades of experience with the group. Its mission was to reaffirm the company’s leading role in diagnostic medicine, while also leading its expansion into new specialties, platforms, and service models. The work involved engaging different stakeholders – from the press to investors – with a narrative marked by transparency and consistency.